Torres, M.; Corona, M.; RodrÃguez-Mora, S.; Casado-Fernández, G.; Zurdo-Castronuño, A.; Mateos, E.; Ramos-MartÃn, F.; Sánchez-Menéndez, C.; Murciano-Antón, M.A.; GarcÃa-Pérez, J.;
et al. Strong Humoral but Not Cellular Immune Responses against SARS-CoV-2 in Individuals with Oncohematological Disease Who Were Treated with Rituximab before Receiving a Vaccine Booster. Cancers 2022, 14, 5537.
https://doi.org/10.3390/cancers14225537
AMA Style
Torres M, Corona M, RodrÃguez-Mora S, Casado-Fernández G, Zurdo-Castronuño A, Mateos E, Ramos-MartÃn F, Sánchez-Menéndez C, Murciano-Antón MA, GarcÃa-Pérez J,
et al. Strong Humoral but Not Cellular Immune Responses against SARS-CoV-2 in Individuals with Oncohematological Disease Who Were Treated with Rituximab before Receiving a Vaccine Booster. Cancers. 2022; 14(22):5537.
https://doi.org/10.3390/cancers14225537
Chicago/Turabian Style
Torres, Montserrat, Magdalena Corona, Sara RodrÃguez-Mora, Guiomar Casado-Fernández, Alejandro Zurdo-Castronuño, Elena Mateos, Fernando Ramos-MartÃn, Clara Sánchez-Menéndez, MarÃa Aranzazú Murciano-Antón, Javier GarcÃa-Pérez,
and et al. 2022. "Strong Humoral but Not Cellular Immune Responses against SARS-CoV-2 in Individuals with Oncohematological Disease Who Were Treated with Rituximab before Receiving a Vaccine Booster" Cancers 14, no. 22: 5537.
https://doi.org/10.3390/cancers14225537
APA Style
Torres, M., Corona, M., RodrÃguez-Mora, S., Casado-Fernández, G., Zurdo-Castronuño, A., Mateos, E., Ramos-MartÃn, F., Sánchez-Menéndez, C., Murciano-Antón, M. A., GarcÃa-Pérez, J., AlcamÃ, J., Pérez-Olmeda, M., Coiras, M., López-Jiménez, J., GarcÃa-Gutiérrez, V., & on behalf of the Multidisciplinary Group of Study of COVID-19 (MGS-COVID).
(2022). Strong Humoral but Not Cellular Immune Responses against SARS-CoV-2 in Individuals with Oncohematological Disease Who Were Treated with Rituximab before Receiving a Vaccine Booster. Cancers, 14(22), 5537.
https://doi.org/10.3390/cancers14225537
